| Gene symbol | CLDN6 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Description | claudin 6 | ||||
| GTO ID | GTC2418 |
| Trial ID | NCT04503278 |
| Disease | Solid Tumor |
| Altered gene | CLDN6 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CLDN6 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Trial to Evaluate the Safety and Efficacy of CLDN6 CAR-T +/- CLDN6 RNA-LPX |
| Year | 2020 |
| Country | Australia |
| Company sponsor | BioNTech Cell & Gene Therapies GmbH |
| Other ID(s) | BNT211-01|2019-004323-20 |
| Cohort 1 | |||||||||
|
|||||||||